Start Investing in StocksTraders beat market returns with our 4X Leverage on Equity Delivery.
Home/ Stocks/ LINCOLN
L

LINCOLN PHARMA LTD Share Price | Rupeezy

LINCOLN
₹580 2.000.35 %(in 1 day)
Overview
F&O
News
Open577
Close578
High586
Low570
Volume37207

LINCOLN Fundamentals

ROCE
21.61
Earning/Share
43.57
Dividend Yield
0.44
P/E Ratio
9.3
P/B Ratio
1.35
Debt to Equity
0

LINCOLN Financials

146.45 CrDec'23 (Standalone)
QTR
YR
All values in Rs. Cr
Shareholding Pattern
About Company

Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in Jan 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. 95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The company was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals.The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.96 to part-finance its project.The Company launched Next Generation Progesterone Therapy ProlinSpray during the year 2018. During the year 2021-22, Lincoln Parenteral Limited (Transferor Company), an erstwhile subsidiary, merged with Lincoln Pharmaceuticals Limited (the Transferee Company) through the Scheme of Amalgamation and consequent to this, the Transferor Company ceases to be the subsidiary of the Company. The Company acquired a plant in Mehsana, Gujarat to launch Cephalosporin products in 2022.
Show More
FAQs on LINCOLN PHARMA LTD

Ans: Share price of LINCOLN PHARMA LTD is 580 today.

Ans: LINCOLN PHARMA LTD opened at 577 today.

Ans: LINCOLN PHARMA LTD closed at 578 previous trading day

Ans: Today's High price of LINCOLN PHARMA LTD is : 586 and Today's Low price of LINCOLN PHARMA LTD is : 570

Ans: 52 weeks High price of LINCOLN PHARMA LTD is : 0

Ans: 52 weeks High price of LINCOLN PHARMA LTD is : 0

Ans: P/E ratio of LINCOLN PHARMA LTD is : 9.3

Ans: P/B ratio of LINCOLN PHARMA LTD is : 1.35

Ans: You can buy/sell LINCOLN PHARMA LTD through Rupeezy App or Rupeezy Web